IP Library Granted Patent US 7,691,826
Granted Patent B2
US 7,691,826 · App. 10/568,111 · Granted Apr 6, 2010

Polysialic acid derivatives

Assignee: Lipoxen Technologies Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,691,826
App. No.
10/568,111
Granted
Apr 6, 2010
Kind
B2
Abstract

A polysialic acid compound is reacted with a hetero-bifunctional reagent to introduce a pendant functional group for site-specific conjugation to sulfhydryl groups, for instance side chains of cysteine units in drugs, drug delivery systems, proteins or peptides. The functional group is, for instance, an N-maleimide group.

Claims (20)

1. A compound comprising a polysaccharide having at least two sialic acid units linked 2.8 and/or 2.9 to one another, and having reducing and non-reducing terminal units and said polysaccharides having a pendant moiety linked to the reducing terminal sialic acid unit which pendant moiety includes a functional group selected from N-maleimide, vinyl sulfone, N-iodoacetamide and orthopyridyl disulfide.

2. A compound of claim 1 wherein the pendant moiety further comprises alkylene and/or arylene and/or an oxalkylene and/or oligooxa-alkylene and/or oligopeptide.

3. A compound of claim 1 wherein the functional group is N-maleimido.

4. A compound of claim 1 wherein the polysaccharide is a polysialic acid.

5. The compound of claim 1 which has the formula

wherein:

R 1 is H or —CHOHCH 2 OH,

R 3 is —CH 2 CHR 4 R 5 or —CH(CH 2 OH)CHR 4 R 5 wherein R 4 and R 5 together represent ═N—NR 6 or R 4 is H and R 5 is —NR 6 R 7 in which R 6 is an organic group comprising the said pendant functional group and R 7 is H;

O-Gly is a glycosyl (saccharide) group;

n is 1-50; and

Ac is acetyl.

6. A compound of claim 5 in which each O-Gly is a sialic acid unit.

7. A polysialylated protein with at least one cysteine unit linked through a thioether bond to at least one reducing terminal unit of a polysialic acid.

8. A compound of claim 1 wherein polysaccharide has at least 10 saccharide units.

9. A process to prepare a polysialylated protein coupled to the reducing terminal unit of a polysaccharide which method comprises reacting the compound of claim 3 with a protein having at least one free unprotected cysteine whereby the N-maleimido group forms a thioether linkage with the thiol group of said cysteine.

10. A process to prepare a polysialylated protein which comprises reacting the compound of claim 1 with a protein having at least one-cysteine whereby the said functional group forms a thioether linkage with the thiol group of said cysteine.

11. The compound of claim 4 wherein said polysaccharide consists essentially of sialic acid units and said pendant moiety.

12. The compound of claim 8 wherein the polysaccharide has at least 50 saccharide units.

13. A compound of claim 4 wherein polysaccharide has at least 10 saccharide units.

14. A compound of claim 6 wherein polysaccharide has at least 10 saccharide units.

Assignments (2)
SECURITY INTEREST Recorded Sep 15, 2015
From: LIPOXEN TECHNOLOGIES LIMITED
To: OPKO PHARMACEUTICALS, LLC
Reel/Frame 036567/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2006
From: HRECZUK-HIRST, DALE HOWARD; JAIN, SANJAY; LAING, PETER; GREGORIADIS, GREGORY; PAPAIOANNOU, IOANNIS
To: LIPOXEN TECHNOLOGIES LIMITED
Reel/Frame 018193/0778 →
Priority Claims (2)
EP 03254988 · Aug 12, 2003 · regional
EP 03255200 · Aug 21, 2003 · regional
Continuity (1)
Related Publication 20060270830A1 · Nov 30, 2006